Related Experiment Videos
Translational regulation is a control point in RUNX2/Cbfa1 gene expression
1Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, Texas 78229, USA.
Biochemical and Biophysical Research Communications
|November 22, 2001
Summary
Runt-related transcription factor-2 (RUNX2) mRNA is present but inactive in early bone cells. RUNX2 protein expression is controlled by translation, regulating osteoblast differentiation and isoform-specific protein production.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cell Biology
Background:
- Runt-related transcription factor-2 (RUNX2), also known as core binding factor a1 (Cbfa1), is crucial for osteoblast differentiation and gene expression.
- RUNX2 mutations lead to cleidocranial dysplasia, a skeletal disorder.
- Two RUNX2 mRNA isoforms (type-I and type-II) exist.
Purpose of the Study:
- To investigate the regulation of RUNX2 expression during osteoblast differentiation.
- To determine the translational control of RUNX2 gene expression.
- To examine the stage-specific expression of RUNX2 protein isoforms.
Main Methods:
- Detection of RUNX2 mRNAs in various cell types (osteoblastic cells, osteoblast precursors, nonosteoblastic cells).
- Analysis of RUNX2 protein expression in relation to cell differentiation stage.
- Northern blot analysis of polysome-associated and polysome-free RUNX2 mRNA.
Main Results:
- Both RUNX2 mRNA isoforms are detected in osteoblast precursors and nonosteoblastic cells, but no RUNX2 protein is expressed.
- Mature osteoblasts express both RUNX2 isoforms, while less mature osteoblasts express only type-I.
- RUNX2 mRNA is polysome-associated in osteoblastic cells but polysome-free in osteoblast precursors.
Conclusions:
- RUNX2 mRNAs are expressed but translationally repressed in osteoblast precursors and nonosteoblastic cells.
- RUNX2 gene expression is primarily regulated at the translational level.
- The expression of RUNX2 protein isoforms is specific to the differentiation stage, indicating translational control of osteoblast lineage differentiation.